ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0945

Nerve Injury-Induced Protein-1 (Ninj1) Deficiency Aggravates Murine Lupus Through Modulation of Macrophage Polarization

Jorge Romo-Tena1, Luz Blanco2, Shuichiro Nakabo3, Victoria Hoffman4, Norio Hanata5, Mingzeng Zhang2, Carmelo Carmona-Rivera5, Eduardo Patino-Martinez6, Dillon Claybaugh2, Zu-Xi Yu2 and Mariana Kaplan5, 1Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 2NIH, Bethesda, MD, 3NIAMS, NIH, Bethesda, MD, 4Diagnostic and Research Services Branch, Division of Veterinary Resources, Office of Research Services, National Institutes of Health, Bethesda, MD, Bethesda, 5Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, Bethesda, MD, 6NIH/NIAMS, Bethesda, MD

Meeting: ACR Convergence 2025

Keywords: innate immunity, Lupus nephritis, macrophages, Mouse Models, Lupus, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0934–0954) Systemic Lupus Erythematosus – Animal Models Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Nerve injury-induced protein-1 (Ninj1) is an adhesion molecule that plays various roles in immune and stromal cells, including the modulation of inflammation and a critical role during cell death. Dysregulation of inflammatory pathways and cell death has been linked to the development of autoimmune diseases, such as systemic lupus erythematosus (SLE). Therefore, we hypothesized that Ninj1 may be involved in the pathogenesis of SLE.

Methods: Ninj1-deficient (Ninj1+/-) and wild-type (WT) C57/B6 mice were induced to develop lupus-like autoimmunity using two induced models triggered by topical application of the Toll-like receptor 7/8 (TLR7/8) agonist imiquimod (IMQ) or by intraperitoneal injection of pristane. We assessed the mice for clinical phenotype, immune dysregulation, and organ damage.

Results: In comparison to WT mice, Ninj1+/- mice exposed to IMQ exhibited greater splenomegaly at the expense of extramedullary hematopoiesis, more severe anemia, decreased spleen lymphocyte counts, and increased spontaneous neutrophil extracellular trap (NET) formation. Although we observed no differences in autoantibody levels or proteinuria, Ninj1+/- mice developed more lupus-associated renal disease, as evidenced by increased immune complex deposition and exacerbated kidney inflammation and damage. In the pristane model, Ninj1 deficiency worsened diffuse alveolar hemorrhage and lung inflammation. Furthermore, Ninj1+/- M2 bone marrow-derived macrophages (BMDM) exposed to IMQ in vitro showed defective activation of the p38/Erk 1/2 mitogen-activated protein kinase (MAPK) and Akt signaling pathways, which are important in M2 macrophage polarization.

Conclusion: Preliminary, these findings suggest that Ninj1 deficiency aggravates murine lupus, at least in part, by impairing the anti-inflammatory roles of M2 macrophages. Further experimentation is needed to identify the immune system defects associated with Ninj1 deficiency, particularly in the affected tissues, and to understand their implications for autoimmune diseases.


Disclosures: J. Romo-Tena: None; L. Blanco: None; S. Nakabo: None; V. Hoffman: None; N. Hanata: None; M. Zhang: None; C. Carmona-Rivera: None; E. Patino-Martinez: None; D. Claybaugh: None; Z. Yu: None; M. Kaplan: None.

To cite this abstract in AMA style:

Romo-Tena J, Blanco L, Nakabo S, Hoffman V, Hanata N, Zhang M, Carmona-Rivera C, Patino-Martinez E, Claybaugh D, Yu Z, Kaplan M. Nerve Injury-Induced Protein-1 (Ninj1) Deficiency Aggravates Murine Lupus Through Modulation of Macrophage Polarization [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/nerve-injury-induced-protein-1-ninj1-deficiency-aggravates-murine-lupus-through-modulation-of-macrophage-polarization/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nerve-injury-induced-protein-1-ninj1-deficiency-aggravates-murine-lupus-through-modulation-of-macrophage-polarization/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology